Showing posts with label new drugs. Show all posts
Showing posts with label new drugs. Show all posts
Thursday, April 19, 2012
Emerging Therapies for Ovarian Cancer - Chemotherapy Advisor
Emerging Therapies for Ovarian Cancer - Chemotherapy Advisor
Bevacizumab
Other Antiangiogenesis Agents
Poly(ADP-ribose) Polymerase Inhibitors
Other Novel Agents in Ovarian Cancer
printer-friendly (view all on one page): link
Sunday, June 05, 2011
extract: Balancing Access and Evaluation in the Approval of New Cancer Drugs, June 8, 2011 — JAMA (patient safety etc)
".....Patients with cancer who lack effective treatment desperately seek novel interventions that might extend their lives. They do not have time to wait for the US Food (blogger's note - or any other nation) and Drug Administration's (FDA’s) regular approval process, which requires that sponsors demonstrate “substantial evidence of clinical benefit (or efficacy) from adequate and well-controlled investigations.”........
add your opinions
access fda
,
approvals
,
new drugs
,
patient safety
Subscribe to:
Posts
(
Atom
)